UK study tests newborn screening for rare muscle disease
NCT ID NCT05481164
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at whether it is practical and acceptable to screen all newborns for spinal muscular atrophy (SMA), a rare genetic disease that causes muscle weakness and can be fatal if not treated early. Over 33,000 babies were screened using a simple blood spot test. The goal was to see how many parents agreed to screening and how reliable the test was, with the hope that early detection could lead to better outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could pave the way for nationwide newborn screening for SMA, allowing early diagnosis and treatment before symptoms appear.
What could go wrong
This is a feasibility study, not a treatment trial. It only measures uptake and accuracy of screening, not long-term health outcomes. Results may not apply outside the UK.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCULAR ATROPHY, SPINAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Buckinghamshire HealthCare Trust
Buckingham, United Kingdom
-
Dorset County Hospital (DCHFT)
Dorchester, DT1 2JY, United Kingdom
-
Milton Keynes University Hospital NHS Foundation Trust
Milton Keynes, United Kingdom
-
Princess Anne Hospital
Southampton, United Kingdom
-
Queen Alexandra Hospital
Portsmouth, United Kingdom
-
Royal Berkshire NHS Foundation Trust
Reading, United Kingdom
-
Salisbury District Hospital
Salisbury, United Kingdom
-
St Mary's Maternity Hospital
Poole, United Kingdom
-
University of Oxford UK
Oxford, United Kingdom